| scholarly article | Q13442814 |
| P2093 | author name string | Smith AG | |
| Francis JE | |||
| P2860 | cites work | Investigations on the role of free radical processes in hexachlorobenzene-induced porphyria in mice | Q68050343 |
| Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study | Q68071090 | ||
| Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and Ahb-3 alleles | Q68478197 | ||
| Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls | Q68486268 | ||
| Protection against iron-induced uroporphyria in C57BL/10ScSn mice by the peroxisome proliferator nafenopin | Q68644646 | ||
| Role of inducer binding in cytochrome P-450 IA2-mediated uroporphyrinogen oxidation | Q68671012 | ||
| Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations | Q69114474 | ||
| Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenoxazones in hepatic S9s and hepatocyte homogenates: effects of dicumarol | Q69381361 | ||
| Uroporphyria caused by acetone and 5-aminolevulinic acid in iron-loaded mice | Q69403215 | ||
| Pleiotropic effect of the gene hairless on hepatotoxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mice | Q69416113 | ||
| Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion | Q69540081 | ||
| Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria | Q69586167 | ||
| The murine Ah locus: a new allele and mapping to chromosome 12 | Q69810190 | ||
| Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase | Q69830407 | ||
| The role of iron in the toxicity of 2,3,7,8-tetrachlorodibenzo-(p)-dioxin (TCDD) | Q70959490 | ||
| Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo(p)dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness | Q71225920 | ||
| In vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from TCDD treated mice | Q71266021 | ||
| Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias | Q71350915 | ||
| Iron storage in porphyria cutanea tarda | Q71665335 | ||
| Induction of Hepatic δ-Aminolevulinic Acid Synthetase Activity in Strains of Inbred Mice | Q71755429 | ||
| A simple technique for measuring storage iron concentrations in formalinised liver samples | Q72104635 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450IA2 | Q28319534 | ||
| The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice | Q28359863 | ||
| Rare structural variants of human and murine uroporphyrinogen I synthase | Q36389804 | ||
| The Ah receptor and the mechanism of dioxin toxicity | Q36390569 | ||
| Isolation of a rat liver delta-aminolevulinate dehydrase (ALAD) cDNA clone: evidence for unequal ALAD gene dosage among inbred mouse strains | Q36460920 | ||
| The pathology of hepatic iron overload: a free radical--mediated process? | Q37870467 | ||
| Oxidative injury mediated by the hepatic cytochrome P-450 system in conjunction with cellular iron. Effects on the pathway of haem biosynthesis | Q37990265 | ||
| Experimental porphyria | Q39312894 | ||
| Toxicological aspects of liver heme biosynthesis | Q39556858 | ||
| Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases | Q39729523 | ||
| Uroporphyria produced in mice by iron and 5-aminolevulinic acid | Q41186367 | ||
| HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda | Q41326433 | ||
| Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria. | Q41388086 | ||
| Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda | Q41496135 | ||
| Iron Deficiency Prevents Liver Toxicity of 2,3,7,8-Tetrachlorodibenzo- p -Dioxin | Q41521465 | ||
| Identification of meso-hydroxyuroporphyrin I in the urine of a patient with congenital erythropoietic porphyria | Q41763290 | ||
| Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload | Q41860271 | ||
| Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P-450. Essential role of cytochrome P-450d | Q41894823 | ||
| Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice | Q41938430 | ||
| Multiple forms of cytochrome P-450 related to forms induced marginally by phenobarbital. Differences in structure and in the metabolism of alkoxyresorufins | Q42165163 | ||
| Distinction between octachlorostyrene and hexachlorobenzene in their potentials to induce ethoxyphenoxazone deethylase and cause porphyria in rats and mice | Q42212237 | ||
| Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism | Q42854602 | ||
| Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid | Q42858662 | ||
| Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda | Q43545586 | ||
| Free radical mechanism of oxidation of uroporphyrinogen in the presence of ferrous iron | Q44278223 | ||
| Experimental porphyrias as models for human hepatic porphyrias | Q44701010 | ||
| Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda | Q44872150 | ||
| Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in C57BL/10ScSn mice | Q45137320 | ||
| Linkage analyses using biochemical variants in mice. II. Levulinate dehydratase and autosomal glucose 6-phosphate dehydrogenase | Q45269597 | ||
| Investigations on the presence of porphyrinogen carboxy-lyase inhibitor in the liver of rats intoxicated with hexachlorobenzene | Q52535345 | ||
| Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254 | Q53492356 | ||
| Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/10ScSn mice | Q53509364 | ||
| Low rate of NADPH/ADP-iron dependent lipid peroxidation in hepatic microsomes of DBA/2 mice | Q54449975 | ||
| Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice | Q54472965 | ||
| Genetic variance of laboratory outbred Swiss mice | Q59062723 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic variation | Q349856 |
| P304 | page(s) | 29-35 | |
| P577 | publication date | 1993-04-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Genetic variation of iron-induced uroporphyria in mice | |
| P478 | volume | 291 ( Pt 1) |
| Q28507743 | A mouse model of familial porphyria cutanea tarda |
| Q24681370 | A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda |
| Q46290725 | Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate |
| Q34555359 | Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal |
| Q44448362 | Experimental hepatic uroporphyria induced by the diphenyl-ether herbicide fomesafen in male DBA/2 mice |
| Q33609861 | Hyper- and hypo-induction of cytochrome P450 activities with Aroclor 1254 and 3-methylcholanthrene in Cyp1a2(-/-) mice |
| Q73048056 | Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda |
| Q46497692 | Inducing coproporphyria in rat hepatocyte cultures using cyclic AMP and cyclic AMP-releasing agents |
| Q42545416 | Interaction between Iron Metabolism and 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Mice with Variants of the Ahr Gene: A Hepatic Oxidative Mechanism |
| Q72285937 | Isolation and characterization of extragenic mutations affecting the expression of the uroporphyrinogen decarboxylase gene (HEM12) in Sacharomyces cerevisiae |
| Q77893629 | Liver preneoplastic changes in mice treated with the herbicide fomesafen |
| Q48771719 | Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. |
| Q78049632 | Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice |
| Q74178122 | Sensitivity of CYP1A1 mRNA inducibility by dioxin is the same in Cyp1a2(+/+) wild-type and Cyp1a2(-/-) null mutant mice |
| Q28579667 | The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage |
| Q42519264 | Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron |
| Q39345761 | Uroporphyria in the Cyp1a2-/- mouse |
| Q42527457 | Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice |
| Q28506791 | Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(−/−) null mutant mice |
| Q40433950 | Uroporphyrinogen decarboxylase |
Search more.